DocGo

At-home Healthcare Expansion Will Capture Growing Demand

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

24 Sep 24

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-74.3%

1.9%

-74.3%

1.9%

You can edit this narrative until May 12 6:00 AM. Then, changes will post as Updates.

Author's Valuation

US$3.0865.9% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Fair value Decreased 30%

Shared on 23 Apr 25

Fair value Increased 44%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Decreased 30%

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 11 Mar 25

Fair value Increased 65%

AnalystConsensusTarget has decreased revenue growth from -20.5% to -6.4%, decreased profit margin from 1.5% to 1.2% and decreased future PE multiple from 169.7x to 99.4x.

AnalystConsensusTarget Fair Value

US$3.08

65.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

-7.75%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.96%

Calculation

US$15.48m

Earnings '28

20.80x

PE Ratio '28

US$321.99m

Market Cap '28

US$321.99m

Market Cap '28

86.11m

No. shares '28

US$3.74

Share Price '28

US$3.74 Share Price '28

Discounted to 2025 @ 6.78% p.a.

US$3.07

Fair Value '25